To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
May 1, 2006
Scott A. Armstrong, MD, PhD (Damon Runyon Clinical Investigator '03-'08) and colleagues reported on the mechanism of action of a new small molecule inhibitor targeting BCL-2, a key protein in the cell death machinery. Dr. Armstrong's findings were published in the May issue of the prestigious journal, Cancer Cell.
---
Andrew G. Dillin, PhD (Damon Runyon Fellow '99-'01), an assistant professor in the Molecular and Cell Biology Laboratory at the Salk Institute in La Jolla, California, was featured in the May issue of Inside Salk. Dr. Dillin and his colleagues recently described a protein called Smk-1, which is responsible for extending life span in response to lower insulin signaling.
---
Jedd D. Wolchok, MD, PhD (Damon Runyon Clinical Investigator '03-'08) published new data detailing recent advances in the optimization of a DNA vaccine for melanoma. Dr. Wolchok's work was published in the May 1 issue of Cancer Research.